(m, 8 H, CH2, cyclohexenyl); 13C NMR (75 MHz, CDCl3):
δ 146.74 (s), 145.25 (s), 135.95 (s), 135.27 (s), 135.23 (s), 135.04
(s), 126.68 (d), 126.64 (d), 124.41 (d), 123.07 (d), 119.36 (d),
118.32 (d), 118.24 (d), 117.47 (d), 87.51 (d, O–C, bridgehead),
86.72 (d, O–C, bridgehead), 42.56 (d), 40.71 (d), 26.40 (t), 26.22
(t), 25.78 (t), 22.95 (t), 22.38 (t), 22.25 (t); MS (FAB): [m/z, (%)]
356 [(M Ϫ H)ϩ, 17.9], 255 (87.9), 238 [(M Ϫ C8H6O)ϩ, 100], 118
(C8H6Oϩ, 76.4); HRMS (M Ϫ 1): calcd for C26H27O 355.2064,
found 355.2058.
MHz, CDCl3): δ 7.26 (m, 2 H, benzo), 7.15 (m, 2 H, benzo),
5.52 (br s, 2 H, ᎐CH, cyclohexadiene), 5.16 (s, 2 H, O–CH,
᎐
bridgehead), 2.69 (br s, 2 H, endo cyclohexadiene), 2.34 (m, 4 H,
2 × CH2), 1.77 (m, 1 H), 1.62 (m, 1 H); 13C NMR (75 MHz,
CDCl3): δ 146.22 (s), 139.65 (s), 126.54 (d), 118.89 (d), 115.37
(d), 86.62 (d, O–C, bridgehead), 42.03 (d), 31.38 (t), 24.48 (t);
MS (FAB): [m/z, (%)] 236 (Mϩ, 5.1), 154 (16.6), 136 (15.1), 118
[(C8H6O)ϩ, (C9H10)ϩ, 100]; HRMS: calcd for C17H16O 236.1201,
found 236.1198.
(1S*,2R*,11S*,12R*)-19-Oxapentacyclo[10.6.1.02,11.04,9.-
(1R*,8S*,9R*,14S*)-10,12-Di(cyclohex-1-enyl)-15-[(4-meth-
ylphenyl)sulfonyl]-15-azatetracyclo[6.6.1.02,7.09,14]pentadeca-
2,4,6,10,12-pentaene 4h. Yield 90%. 1H NMR (300 MHz,
CDCl3): δ 7.42 (d, J = 8.1 Hz, 2 H, tosyl), 7.11–6.85 (m, 6 H,
benzo tosyl), 6.24 (s, 1 H, cyclohexadiene), 5.99 (br s, 1 H, cyclo-
hexenyl), 5.81 (br s, 1 H, cyclohexenyl), 5.58 (br s, 1 H,
cyclohexenyl), 4.84 (s, 1 H, N–CH, bridgehead), 4.76 (s, 1 H,
1
0
13,18]nonadeca-3,9,13,15,17-pentaene 6b. Yield 70%. H NMR
(300 MHz, CDCl3): δ 7.22 (m, 2 H, benzo), 7.13 (m, 2 H,
benzo), 5.39 (br s, 2 H, ᎐CH, cyclohexadiene), 5.15 (s, 2 H, O–
᎐
CH, bridgehead), 2.62 (br s, 2 H, endo cyclohexadiene), 2.26 (m,
4 H, 2 × CH2), 1.57 (m, 4 H, 2 × CH2); 13C NMR (75 MHz,
CDCl3): δ 146.09 (s), 133.59 (s), 126.54 (d), 119.95 (d), 118.89
(d), 86.63 (d, O–C, bridgehead), 41.28 (d), 29.83 (t), 23.13 (t);
MS (FAB): [m/z, (%)] 250 (Mϩ, 9.4), 233 (22.3), 132
[(M Ϫ C8H6O)ϩ, 8.2], 118 [(C8H6O)ϩ, 100]; HRMS: calcd for
C18H18O 250.1357, found 250.1363.
N–CH, bridgehead), 2.82 (br s, 2 H, ᎐CH, endo cyclohexa-
᎐
diene), 2.28 (s, 3 H, CH3), 2.23 (m, 8 H, –CH2–, cyclohexenyl),
1.66 (m, 8 H, CH2, cyclohexenyl); 13C NMR (75 MHz, CDCl3):
δ 145.20 (s), 138.18 (s), 136.92 (s), 135.98 (s), 135.55 (s), 134.45
(s), 128.77 (d), 127.91 (d), 126.72 (d), 124.22 (d), 123.08 (d),
120.31 (d), 119.14 (d), 118.36 (d), 117.51 (d), 71.55 (d, N–C,
bridgehead), 70.26 (d, N–C, bridgehead), 43.17 (d), 41.87 (d),
26.32 (t), 26.21 (t), 25.81 (t), 22.93 (t), 22.88 (t), 22.30 (t), 22.27
(t), 21.38 (q); MS (FAB): [m/z, (%)] 509 (Mϩ, 2.1), 271
(C15H13NSO2ϩ, 91.6), 91 (C7H7)ϩ; HRMS (FAB): calcd for
C33H35NSO2 509.2388, found 509.2398.
(1S*,2R*,10S*,11R*)-18-[(4-Methylphenyl)sulfonyl]-18-
azapentacyclo[9.6.1.02,10.04,8.012,17]octadeca-3,8,12,14,16-
pentaene 6c. Yield 71%. 1H NMR (300 MHz, CDCl3): δ 7.40 (d,
J = 8.23 Hz, 2 H, tosyl H), 6.99–6.91 (m, 6 H, aromatic), 5.43
(br s, 2 H, ᎐CH, cyclohexadiene), 4.78 (s, 2 H, N–CH, bridge-
᎐
head), 2.61 (br s, 2 H, endo cyclohexadiene H), 2.31 (m, 4 H,
2 × CH2), 2.27 (s, 3 H, CH3), 1.76 (m, 1 H), 1.64 (m, 1 H); 13
C
(1S*,8R*,9S*,14R*)-10,12-Diphenyl-3-methoxy-15-oxatetra-
NMR (75 MHz, CDCl3): δ 144.39 (s), 142.64 (s), 140.43 (s),
136.05 (s), 128.75 (d), 127.82 (d), 126.56 (d), 119.86 (d), 114.59
(d), 70.90 (d, N–C, bridgehead), 42.87 (d), 31.41 (t), 24.54 (t),
21.36 (q); MS (FAB): [m/z, (%)] 390 (M ϩ 1, 6.7), 271
(C15H13NSO2ϩ, 100), 155 (25.4), 91 (45.4); HRMS (Mϩ1): calcd
for C24H24NSO2 390.1528, found 390.1518.
cyclo[6.6.1.02,7.09,14]pentadeca-2,4,6,10,12-pentaene
4i
and
(1S*,8R*,9S*,14R*)-10,12-diphenyl-6-methoxy-15-oxatetra-
cyclo[6.6.1.02,7.09,14]pentadeca-2,4,6,10,12-pentaene 4iЈ. Com-
bined yield 72%. The following two sets of spectral data are for
1
compounds 4i and 4iЈ. H NMR (300 MHz, CDCl3): δ 7.50–
6.80 (m, 13 H, phenyl, benzo), 6.70 (s, 1 H, cyclohexadiene),
6.02 (d, J = 4.5 Hz, 1 H, cyclohexadiene), 5.60 (s, 1 H, O–CH,
bridgehead), 5.24 (s, 1 H, O–CH, bridgehead), 3.86 (s, 3 H,
OCH3), 3.31 (d, J = 11.5 Hz, 1 H, endo cyclohexadiene), 3.11
(1S*,2R*,11S*,12R*)-19-[(4-Methylphenyl)sulfonyl]-19-aza-
pentacyclo[10.6.1.02,11.04,9.013,18]nonadeca-3,9,13,15,17-pentaene
6d. Yield 75%. 1H NMR (300 MHz, CDCl3): δ 7.43 (d, J = 8.27
Hz, 2 H, tosyl H), 7.01–6.92 (m, 6 H, aromatic), 5.32 (br s, 2 H,
(dd, J = 11.5 Hz, J = 4.5 Hz, 1 H, ᎐CH, endo cyclohexadiene);
᎐
MS (FAB): [m/z, (%)] 337 [(M ϩ 1)ϩ, 15.0], 361 [(M Ϫ O)ϩ,
16.8], 307 (13.63).
᎐CH, cyclohexadiene), 4.79 (s, 2 H, N–CH, bridgehead), 2.57
᎐
(br s, 2 H, endo cyclohexadiene H), 2.28 (s, 3 H, CH3), 2.25 (m, 4
H, 2 × CH2), 1.59 (m, 4 H, 2 × CH2); 13C NMR (75 MHz,
CDCl3): δ 144.62 (s), 142.65 (s), 135.61 (s), 134.38 (s), 128.76
(d), 127.76 (d), 126.54 (d), 119.83 (d), 119.06 (d), 70.88 (d, N–C,
bridgehead), 42.08 (d), 29.77 (t), 23.03 (t), 21.34 (q); MS (FAB):
[m/z, %)] 404 (M ϩ 1, 3.3), 271 (C15H13NSO2ϩ, 100), 155 (23.5),
91 (47.7); HRMS (Mϩ1): calcd for C25H26NSO2 404.1684,
found 404.1675.
1H NMR (300 MHz, CDCl3): δ 7.50–6.80 (m, 13 H, phenyl,
benzo), 6.75 (s, 1 H, cyclohexadiene), 6.10 (d, J = 4.5 Hz, 1 H,
cyclohexadiene), 5.52 (s, 1 H, O–CH, bridgehead), 5.38 (s, 1 H,
O–CH, bridgehead), 3.86 (s, 3 H, OCH3), 3.31 (d, J = 11.5 Hz,
1 H, endo cyclohexadiene), 3.04 (dd, J = 11.5 Hz, J = 4.5 Hz, 1
H, ᎐CH, endo cyclohexadiene); MS (FAB): [m/z, (%)] 337
᎐
[(M ϩ 1)ϩ, 15.0], 361 [(M Ϫ O)ϩ, 16.8], 307 (13.63).
(1S*,8R*,9S*,14R*)-3,6-Dimethoxy-10,12-diphenyl-15-oxa-
tetracyclo[6.6.1.02,7.09,14]pentadeca-2,4,6,10,12-pentaene
4j.
Diels–Alder cycloaddition of in situ generated isobenzofuran
or isoindole with 1a. To a 50 ml round-bottomed side-arm flask
consisting of 6c (or 6d) (0.0720 mmol) and 1a (0.0104 g, 0.0720
mmol) was added freshly distilled xylene (5.0 ml). The system
was evacuated and purged with nitrogen gas three times. The
reaction mixture was then heated at 90 ЊC for 7.5 h. The solvent
was removed under vacuum and the resulting solid was purified
by silica gel column using a mixture of hexanes–ethyl acetate
(v/v = 7/3) as eluent to give 10 in 70% yield.
1
Yield 74%. H NMR (300 MHz, CDCl3): δ 7.40 (m, 10 H,
phenyl), 6.79 (s, 1 H, cyclohexadiene), 6.71 (br s, 2 H, dimeth-
oxybenzo), 6.09 (d, J = 4.4 Hz, 1 H, cyclohexadiene), 5.58 (s, 1
H, O–CH, bridgehead), 5.50 (s, 1 H, O–CH, bridgehead), 3.83
(s, 3 H, OCH3), 3.80 (s, 3 H, OCH3), 3.32 (d, J = 11.6 Hz, 1 H,
endo cyclohexadiene), 3.11 (dd, J = 11.6 Hz, J = 4.4 Hz, 1 H,
᎐CH, endo cyclohexadiene); 13C NMR (75 MHz, CDCl3):
᎐
δ 146.69 (s), 146.46 (s), 141.72 (s), 141.11 (s), 139.42 (s), 135.67
(s), 135.47 (s), 134.98 (s), 128.74 (d), 128.52 (d), 128.35 (d),
127.34 (d), 127.19 (d), 126.05 (d), 125.82 (d), 125.49 (d), 122.52
(d), 121.89 (d), 85.15 (d, O–C, bridgehead), 84.08 (d, O–C,
bridgehead), 56.16 (q, OCH3), 56.01 (q, OCH3), 42.84 (d), 41.96
(d); MS: [m/z, (%)] 408 (Mϩ, 0.1), 230 [(M Ϫ C18H14)ϩ, 100], 178
[(C10H10O3)ϩ, 1.16]; HRMS: calcd for C28H24O3 408.1725,
found 408.1717.
(1S*,3S*,10R*,12R*)-20-[(4-Methylphenyl)sulfonyl]-19-oxa-
20-azahexacyclo[10.6.1.13,10.02,11.04,9.013,18]icosa-4,6,8,13,15,17-
hexaene 10. 1H NMR (300 MHz, CDCl3): δ 7.34 (d, J = 7.6 Hz,
2 H, tosyl H), 7.12 (m, 4 H, benzo), 7.07 (m, 4 H, benzo), 6.94
(d, J = 6.4 Hz, 2 H, tosyl H), 5.07 (br s, 2 H, O–CH, bridge-
head), 4.66 (s, 2 H, N–CH, bridgehead), 2.95 (br s, 2 H), 2.27 (s,
3 H, CH3); 13C NMR (75 MHz, CDCl3): δ 146.13 (s), 142.84 (s),
141.24 (s), 136.26 (s), 129.85 (d), 128.92 (d), 127.82 (d), 127.35
(d), 126.87 (d), 126.67 (d), 120.43 (d), 118.94 (d), 77.69 (d, C–O,
(1S*,2R*,10S*,11R*)-18-Oxapentacyclo[9.6.1.02,10.04,8.012,17]-
1
octadeca-3,8,12,14,16-pentaene 6a. Yield 62%. H NMR (300
J. Chem. Soc., Perkin Trans. 1, 2000, 195–203
201